CN104042703B - A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application - Google Patents
A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application Download PDFInfo
- Publication number
- CN104042703B CN104042703B CN201410261440.2A CN201410261440A CN104042703B CN 104042703 B CN104042703 B CN 104042703B CN 201410261440 A CN201410261440 A CN 201410261440A CN 104042703 B CN104042703 B CN 104042703B
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- treatment
- rheumatic arthritis
- medicated wine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides a kind of medicated wine being used for the treatment of rheumatic arthritis, it is prepared by the raw material of following parts by weight: Herba Pileae Plataniflorae 10-20 part, Spora Lycopodii 10-20 part, Herba Pratiae Nummulariae 40-60 part, Radix Clematidis 10-20 part, Radix Stephaniae Tetrandrae 15-25 part, Ramulus Cinnamomi 15-25 part, Radix Linderae 10-20 part, Radix Dipsaci 10-20 part, Radix Glycyrrhizae 10-20 part, pass through benefiting QI and nourishing blood, expelling wind and removing dampness, expel wind to dredge collateral, object that dispelling and becoming silted up and reach and treat rheumatic arthritis of reducing phlegm, and disclose preparation method and purposes.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application.
Background technology
Rheumatism is medically the chronic pain of articulations digitorum manus and surrounding soft tissue's unknown cause thereof.Rheumatism then refers to that the different but common ground of a large class cause of disease is for involving joint and surrounding soft tissue, comprises the disease of flesh, ligament, synovial bursa, fascia.Arthropathy has pain outer still with swelling and moving obstacle, in outbreak with the alleviation chronic course of disease alternately.Because the blood circulation of patient is obstructed, cause muscle or the nutrition required for tissue cannot be carried by blood circulation, cause that patient muscle lacks nutrition and accelerated ageing becomes stiff, serious meeting causes patient muscle and blood vessel die back, some patients and can occur disabling and viscera function exhaustion in joint.The Drug therapys such as current domestic clinical conventional nonsteroidal anti-inflammatory agent are all chemical drugss, and side effect is large, and safety is day by day subject to people and pays close attention to.
For this reason, need to develop the needs that more how safe and effective treatment rheumatoid arthritis agents meets clinical treatment.Chinese medicine is in rheumatic arthritis medication market share critical role, because Chinese medicine side effect is little, determined curative effect, is applicable to long-term prescription, and adapted to the feature that rheumatic arthritis easily recurs, clinical practice widely.People are in the urgent need to a kind of effective, own medicated wine that can be played the treatment rheumatic arthritis of good result by most people confirmation.
Summary of the invention
Goal of the invention: in order to solve the problem, the object of the present invention is to provide a kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application.
Technical scheme: the object of the invention is by following scheme realize:
Be used for the treatment of a medicated wine for rheumatic arthritis, it is prepared by the raw material of following parts by weight: Herba Pileae Plataniflorae 10-20 part, Spora Lycopodii 10-20 part, Herba Pratiae Nummulariae 40-60 part, Radix Clematidis 10-20 part, Radix Stephaniae Tetrandrae 15-25 part, Ramulus Cinnamomi 15-25 part, Radix Linderae 10-20 part, Radix Dipsaci 10-20 part, Radix Glycyrrhizae 10-20 part.
The described medicated wine being used for the treatment of rheumatic arthritis, it is prepared by the raw material of following parts by weight: Herba Pileae Plataniflorae 15 parts, Spora Lycopodii 15 parts, Herba Pratiae Nummulariae 45 parts, Radix Clematidis 15 parts, Radix Stephaniae Tetrandrae 20 parts, Ramulus Cinnamomi 20 parts, the Radix Linderae 15 parts, Radix Dipsaci 15 parts, 15 parts, Radix Glycyrrhizae.
The described medicated wine being used for the treatment of rheumatic arthritis, preparation method comprises the steps: to get Herba Pileae Plataniflorae, Spora Lycopodii, Herba Pratiae Nummulariae, Radix Clematidis, Radix Stephaniae Tetrandrae, Ramulus Cinnamomi, the Radix Linderae, Radix Dipsaci, licorice medicinal materials merging, pulverize, add 35-50 degree soaking in Chinese liquor 20 days, Chinese liquor consumption is 20 times of medical material weight, to obtain final product.
The described application of medicated wine in the medicated wine of preparation treatment rheumatic arthritis being used for the treatment of rheumatic arthritis.
Herba Pileae Plataniflorae is the contrayerva southwest herb of Rhizoma Belamcandae, Spora Lycopodii is fern Lycopodiaceae Lycopodium plant Spora Lycopodii Lycopodium clavatum LycopodiumcomplanatumL., with all herbal medicine, Herba Pratiae Nummulariae for campanulaceae Herba pratiae begonifoliae platymiscium Herba pratiae begonifoliae PratiamummulariaA.BrownetAschers., herb, all the other are pharmacopeia kind.
Beneficial effect:
Chinese medicine is thought that human feeling's wind, cold, wet is evil and causes rheumatic arthritis, show as general pain or heavy sensation of the body, arthralgia, joint stuffiness, from theory of Chinese medical science, Herba Pileae Plataniflorae, Spora Lycopodii, Herba Pratiae Nummulariae soothing the channels and quicking the network vessels in we, for monarch drug, Radix Clematidis, Radix Stephaniae Tetrandrae, Ramulus Cinnamomi, the Radix Linderae, Radix Dipsaci expelling wind and removing dampness, benefiting QI and nourishing blood are ministerial drug, increase the effect of monarch drug dredging collateral, Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for adjuvant, all medicines are harmonious, and play benefiting QI and nourishing blood altogether, expelling wind and removing dampness, expel wind to dredge collateral, silt effect of dispelling of reducing phlegm, be used for the treatment of rheumatic arthritis.Formulation of the present invention is reasonable, and compatibility is rigorous, through long-term clinical verification, and determined curative effect.The present invention consists of Chinese crude drug, is pharmacopeia kind, has no side effect, low price.
Detailed description of the invention
Form by the following examples, foregoing of the present invention is described in further detail again, but this should be interpreted as that the scope of the above-mentioned theme of the present invention is only limitted to following example, all technology realized based on foregoing of the present invention all belong to scope of the present invention.
1. prepare embodiment
Embodiment 1: get Herba Pileae Plataniflorae 15 parts, Spora Lycopodii 15 parts, Herba Pratiae Nummulariae 45 parts, Radix Clematidis 15 parts, Radix Stephaniae Tetrandrae 20 parts, Ramulus Cinnamomi 20 parts, the Radix Linderae 15 parts, Radix Dipsaci 15 parts, Radix Glycyrrhizae 15 parts of medical materials merging, pulverize, add 45 degree of soaking in Chinese liquor 20 days, Chinese liquor consumption is 20 times of medical material weight, to obtain final product.
2. the present invention treats the clinical and experimental study of rheumatic arthritis
The preparation of 2.1 samples: prepare by embodiment 1 method.
2.2 clinical cases: 100 routine patients, wherein rheumatic sufferers 67 example, rheumatoid patient 33 example, has 25 examples simultaneously with prolapse of lumbar intervertebral disc, has 32 examples with hyperosteogeny.
2.3 diagnostic criterias: arthralgia, swelling, severe patient ankylosis, deformity and dysfunction, lab testing, erythrocyte sedimentation rate, rheumatoid factor, x-ray inspection etc. can be made a definite diagnosis.
2.4 instructions of taking: take medicated wine of the present invention, early, middle and late three times of every bu, each 20ml one month is a course for the treatment of.
2.5 efficacy assessment standards: cure: arthralgia, swelling disappears, and recovers activities.Take a turn for the better: arthralgia, swelling alleviates, and joint movement function improves.Do not heal: symptom and sign is without improvement.
2.6 therapeutic effect: a month course for the treatment of, a course for the treatment of of the lighter, severe one can take a turn for the better or cure two to three courses for the treatment of.In 100 routine patients, cure 63 examples, take a turn for the better 29 examples, cure rate 63%, improvement rate 29%, effective percentage 92%.
Claims (4)
1. one kind is used for the treatment of the medicated wine of rheumatic arthritis, it is characterized in that, it is prepared by the raw material of following parts by weight: Herba Pileae Plataniflorae 10-20 part, Spora Lycopodii 10-20 part, Herba Pratiae Nummulariae 40-60 part, Radix Clematidis 10-20 part, Radix Stephaniae Tetrandrae 15-25 part, Ramulus Cinnamomi 15-25 part, Radix Linderae 10-20 part, Radix Dipsaci 10-20 part, Radix Glycyrrhizae 10-20 part.
2. the medicated wine being used for the treatment of rheumatic arthritis according to claim 1, it is characterized in that, it is prepared by the raw material of following parts by weight: Herba Pileae Plataniflorae 15 parts, Spora Lycopodii 15 parts, Herba Pratiae Nummulariae 45 parts, Radix Clematidis 15 parts, Radix Stephaniae Tetrandrae 20 parts, Ramulus Cinnamomi 20 parts, the Radix Linderae 15 parts, Radix Dipsaci 15 parts, 15 parts, Radix Glycyrrhizae.
3. the medicated wine being used for the treatment of rheumatic arthritis according to claim 1, it is characterized in that, preparation method comprises the steps: to get Herba Pileae Plataniflorae, Spora Lycopodii, Herba Pratiae Nummulariae, Radix Clematidis, Radix Stephaniae Tetrandrae, Ramulus Cinnamomi, the Radix Linderae, Radix Dipsaci, licorice medicinal materials merging, pulverize, add 35-50 degree soaking in Chinese liquor 20 days, Chinese liquor consumption is 20 times of medical material weight, to obtain final product.
4. described in claim 1, be used for the treatment of the application of medicated wine in the medicated wine of preparation treatment rheumatic arthritis of rheumatic arthritis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410261440.2A CN104042703B (en) | 2014-06-12 | 2014-06-12 | A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410261440.2A CN104042703B (en) | 2014-06-12 | 2014-06-12 | A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104042703A CN104042703A (en) | 2014-09-17 |
| CN104042703B true CN104042703B (en) | 2016-03-23 |
Family
ID=51496426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410261440.2A Expired - Fee Related CN104042703B (en) | 2014-06-12 | 2014-06-12 | A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104042703B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1839952A (en) * | 2005-12-22 | 2006-10-04 | 清华大学深圳研究生院 | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis |
-
2014
- 2014-06-12 CN CN201410261440.2A patent/CN104042703B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1839952A (en) * | 2005-12-22 | 2006-10-04 | 清华大学深圳研究生院 | Traditional Chinese medicine for treating rheumatic and rheumatoid arthritis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104042703A (en) | 2014-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102697899A (en) | Traditional Chinese medicine composition for treating osteoarthritis and preparation method thereof | |
| CN102670928B (en) | Plaster for treating cervical spondylosis and lumbar spondylosis | |
| CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
| CN101912536B (en) | Medicinal composition for treating rheumatism and rheumatoid disease | |
| CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
| CN102078586A (en) | Medicament for treating cervical spondylosis | |
| CN108186749A (en) | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof | |
| CN104162088A (en) | Traditional Chinese medicine composition for relieving rigidity of muscles, activating collaterals and eliminating dampness and preparation method thereof | |
| CN104042703B (en) | A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application | |
| CN102430096B (en) | Medicament for treating rheumatic or rheumatoid diseases | |
| CN105012924A (en) | External medicine for treating rheumatism | |
| CN105012594A (en) | Traditional Chinese medicine for treating knee osteoarthritis | |
| CN101804179B (en) | Traditional Chinese medicine composition for treating hyperosteogeny of cervical vertebra and lumbar vertebra and preparation method thereof | |
| CN100394925C (en) | Chinese medicinal composition for treating rheumatism rheumatoid arthritis and osteosis | |
| CN104491760A (en) | Traditional Chinese medicine composition for treating depression | |
| CN103070994B (en) | Plaster for treating cervical and lumbar spondylosis | |
| CN102614350A (en) | Chinese medicine for treating cervical spondylosis | |
| CN102949672A (en) | Medicine for treating pelvic inflammation | |
| CN103356951B (en) | A kind of Chinese medicine composition for the treatment of cardiac blood supply deficiency | |
| CN102225125B (en) | Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof | |
| CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
| CN101897764A (en) | Chinese medicinal preparation for treating sciatica | |
| CN103070998B (en) | Externally-applied plaster for curing pain of rheumatic joints | |
| CN104474051A (en) | Traditional Chinese medicine for treating arthralgia and preparation method of traditional Chinese medicine | |
| CN104288484A (en) | Medicament for treating bronchitis and asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Mei Inventor before: Xu Yan |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160128 Address after: 273300 No. 33 Hing Shui street, Pingyi County, Linyi, Shandong Applicant after: Li Mei Address before: 211224, No. 18, industrial town, crystal Town, Lishui District, Jiangsu, Nanjing Applicant before: Xu Yan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160323 Termination date: 20160612 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |